Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JOYRAB-20
- Development stage
- Unknown
- Lead developer
- JoY Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
JOYRAB-20 is a branded generic pharmaceutical product marketed by JoY Pharma, containing 20 mg of rabeprazole sodium. Rabeprazole is a substituted benzimidazole that belongs to the class of proton pump inhibitors (PPIs). It is indicated for the treatment of various gastrointestinal disorders, including gastroesophageal reflux disease (GERD), gastric and duodenal ulcers, and pathological hypersecretory conditions such as Zollinger-Ellison syndrome. The drug functions by irreversibly inhibiting the H+/K+ ATPase enzyme system, commonly known as the gastric proton pump, at the secretory surface of the gastric parietal cell. This action effectively blocks the final step of gastric acid secretion, providing relief from acid-related symptoms and promoting the healing of mucosal damage.
- Brand names
- JOYRAB-20JOYRAB20JOYRAB 20
- Other names
- rabeprazole 20 mgrabeprazole20 mgrabeprazole-20 mgrabeprazole sodium
02
Targets
ATP4A (Potassium–transporting ATPase alpha chain 1)
Beyond the preview
Go deeper on JOYRAB-20.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JOYRAB-20.